It is hoped that the dynamic detection of CD4+ T and CD8+ T cells can be used in the clinic in the future to grasp the patient’s disease and eventually eliminate SARS-CoV-2 and prevent the patient from progressing to ARDS (Figure 2). This evidence concerns the gene CD4 and acute respiratory distress syndrome.